Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Aspirin decreases plaque formations that cause heart attacks and strokes

Charles H. Hennekens, M.D., DrPH, the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Medicine at Florida Atlantic University, has published the results of A Randomized Trial of Aspirin at Clinically Relevant Doses and Nitric Oxide Formation in Humans in the current issue of the Journal of Cardiovascular Pharmacology and Therapeutics.

2 Dec 2010

Bone marrow stromal stem cells may aid in stroke recovery: Research

A research study from the Farber Institute for Neurosciences and the Department of Neuroscience at Thomas Jefferson University determines bone marrow stromal stem cells may aid in stroke recovery. The results can be found in Cell Transplantation, The Regenerative Medicine Journal, issue 19(9).

2 Dec 2010

Shire reports topline results from FAST-3 Firazyr Phase III trials for acute attacks of hereditary angioedema

Shire plc, the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase III trials studying the use of Firazyr (icatibant) for treatment of acute attacks of hereditary angioedema (HAE).

2 Dec 2010

Vision problems in stroke patients can impact rehabilitation

Visual problems can affect up to two thirds of stroke patients, but can sometimes go undetected if patients do not recognise them as an after-effect of the condition or if they are unable to communicate the problem to their medical team or families.

2 Dec 2010

Sleep HealthCenters enters agreement with U.S. HealthWorks to provide sleep medicine services

Sleep HealthCenters has entered into an agreement with U.S. HealthWorks to provide sleep medicine services as part of their occupational medicine programs.

2 Dec 2010

Daiichi Sankyo completes patient enrollment in Phase III edoxaban study for AF

Daiichi Sankyo Company, Limited (TSE: 4568) announced today that it has successfully completed patient enrollment for its Phase III ENGAGE AF-TIMI 48 clinical study of edoxaban, a direct, specific, oral Factor Xa inhibitor that is being investigated in two different dosing regimens given once daily, to prevent the occurrence of strokes and systemic embolic events (SEE) in patients with atrial fibrillation (AF).

2 Dec 2010

RegeneRx receives patent for Tβ4 to prevent immunological responses from toxic agents

RegeneRx Biopharmaceuticals, Inc. announced that the Company received a patent in Australia using thymosin beta 4 (Tβ4), and various fragments and anologues of Tβ4, to treat or prevent biological and immunological responses to reactive chemical, biological or toxic agents.

2 Dec 2010

Maintaining ideal BMI reduces mortality risk in healthy non-smoking adults: Study

A study looking at deaths from any cause found that a body mass index (BMI) between 20.0 and 24.9 is associated with the lowest risk of death in healthy non-smoking adults.

1 Dec 2010

Study finds link between osteoporosis and cardiovascular disease

Norwegian studies indicate that people with osteoporosis have a greater risk of developing cardiovascular disease, and vice versa. Now researchers believe they have found a biological system that may influence both disease processes.

1 Dec 2010

New experimental device could offer effective treatment option for people with swallowing disorders

In what might be one of the world's first medicinal body piercings, UC Davis Health System surgeons announced today that they have successfully implanted an experimental device in the throat of a man that will enable him to manually control his ability to swallow.

1 Dec 2010

Clinicians should assess sleep-wake disturbances to understand physiology of Parkinson's disease

Nearly three-quarters of patients with Parkinson's disease experience fatigue or excessive daytime sleepiness (EDS), but clinicians should assess both problems separately in order to improve the profession's understanding of their distinct, but overlapping, physiology. That is the key finding of a study published in the December issue of the European Journal of Neurology.

1 Dec 2010

SILADENT and Innodema appointed as SensAble Authorized Production Centers

SensAble Technologies Inc., a leading provider of dental restoration design and fabrication solutions, 3D modeling software and haptic devices, announced that it has further expanded its network of European partners in service to the growing dental lab business in Europe. The company today announced partnerships with SILADENT Dr. Böhme & Schöps GmbH, Goslar, German and Innodema, an alliance of dental lab fabrication experts based in Belgium, both of whom become SensAble Authorized Production Centers (SAPCs).

1 Dec 2010

Fourteen research projects on population health intervention receive $2.8 million

Fourteen research projects on population health intervention research received $2.8 million in funding. The Vice-President of Research at the Canadian Institutes of Health Research (CIHR), Dr. Pierre Chartrand today announced these initiatives during the Population Health Intervention Research Symposium in Toronto.

1 Dec 2010

Vitamin D supplementation may reduce risk of diabetes, heart disease: Research

Researchers from the UC Davis Health System have found that compared with healthy controls, blood levels of vitamin D are significantly reduced in patients in the Sacramento area with metabolic syndrome, a constellation of disease risk factors that affects about one in three U.S. adults and predisposes them to diabetes, heart disease and stroke.

1 Dec 2010

New tool helps gauge care for people with neurological disorder

A national conversation continues about the best ways to improve both the quality of medical care and to contain costs. So far, developing quality measurements has focused on primary care or highly prevalent, chronic conditions such as asthma and diabetes. But what about brain disorders? To date, the number of measures that apply to neurologic care has been limited.

1 Dec 2010

Common sleep complaints predict development of metabolic syndrome: Study

A study in the Dec. 1 issue of the journal SLEEP found that loud snoring and two common insomnia symptoms difficulty falling asleep and unrefreshing sleep each significantly predicted the development of the metabolic syndrome. The study emphasizes the importance of screening for common sleep complaints in routine clinical practice.

1 Dec 2010

Age-related hearing loss associated with low serum levels of folic acid in the elderly

Age-related hearing loss (ARHL), one of the four most prevalent chronic conditions in the elderly, is associated with low serum levels of folic acid, according to new research published in the December 2010 issue of Otolaryngology - Head and Neck Surgery.

1 Dec 2010

Migraine headache with aura increases risk of stroke among women: Research

Women with a history of migraine headache with aura (transient neurological symptoms, mostly visual impairments) are at increased risk of stroke. However, according to new research reported in Circulation: Journal of the American Heart Association stroke events in women with migraine with aura are more likely to have mild or no disability compared to those without migraine.

1 Dec 2010

Underwood-Memorial Hospital joins Jefferson Neuroscience Network as New Jersey participant

Underwood-Memorial Hospital of Woodbury, New Jersey has joined the Jefferson Neuroscience Network (JNN) as one of the first New Jersey participants. Through this collaboration, Jefferson and Underwood will provide some of the most sophisticated care and expertise available to patients with time-sensitive neurovascular diseases.

1 Dec 2010

NIA awards Aphios Phase I Fast Track SBIR grant for development of novel AD nanodrug

Aphios® Corporation today announced that it was awarded Phase I of a Fast Track SBIR grant from the National Institute of Aging (NIA), National Institutes of Health (NIH) for Developing a Novel Alzheimer's Disease Nanodrug.

30 Nov 2010

Stroke News and Research

Further Reading

Aspirin decreases plaque formations that cause heart attacks and strokes

Bone marrow stromal stem cells may aid in stroke recovery: Research

Shire reports topline results from FAST-3 Firazyr Phase III trials for acute attacks of hereditary angioedema

Vision problems in stroke patients can impact rehabilitation

Sleep HealthCenters enters agreement with U.S. HealthWorks to provide sleep medicine services

Daiichi Sankyo completes patient enrollment in Phase III edoxaban study for AF

RegeneRx receives patent for Tβ4 to prevent immunological responses from toxic agents

Maintaining ideal BMI reduces mortality risk in healthy non-smoking adults: Study

Study finds link between osteoporosis and cardiovascular disease

New experimental device could offer effective treatment option for people with swallowing disorders

Clinicians should assess sleep-wake disturbances to understand physiology of Parkinson's disease

SILADENT and Innodema appointed as SensAble Authorized Production Centers

Fourteen research projects on population health intervention receive $2.8 million

Vitamin D supplementation may reduce risk of diabetes, heart disease: Research

New tool helps gauge care for people with neurological disorder

Common sleep complaints predict development of metabolic syndrome: Study

Age-related hearing loss associated with low serum levels of folic acid in the elderly

Migraine headache with aura increases risk of stroke among women: Research

Underwood-Memorial Hospital joins Jefferson Neuroscience Network as New Jersey participant

NIA awards Aphios Phase I Fast Track SBIR grant for development of novel AD nanodrug

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News